Routine antenatal Rhesus D immunoglobulin prophylaxis: The results of a prospective 10 year study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 5, 1999, Pages 492-497

  MacKenzie, I Z ^a   Bowell, Peter ^b   Gregory, Helen ^a   Pratt, Geoff ^b   Guest, Claire ^b   Entwistle, C C ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY;

ARTICLE; GESTATIONAL AGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; NULLIPARA; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; RHESUS INCOMPATIBILITY;

FEMALE; GESTATIONAL AGE; HUMANS; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PRENATAL CARE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RH ISOIMMUNIZATION; RHO(D) IMMUNE GLOBULIN;

EID: 0032926488     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08304.x     Document Type: Article

References (24)

1. Bowman JM, Chown B, Lewis M, Pollock JM. Rh-isoimmunization during pregnancy: antenatal prophylaxis. Can Med Assoc J 1978; 118: 623-627.
2. Tovey LA, Townley A, Stevenson BJ, Taverner J. The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae. Lancet 1983; 2: 244-246.
3. Bowell PJ, Allen DL, Entwistle CC. Blood group antibody screening tests during pregnancy. Br J Obstet Gynaecol 1986; 93: 1038-1043.
4. Office of Population Censuses and Surveys. Birth Sratistics. Review of the Regisfrar General on births and parterns of family buildirig in Englandand Wales 1982. 1984; 9: 9-15.
5. MacKenzie IZ, Selinger M, Bowell PJ. Management of red cell isoimmunization in the 1990s. In: Studd JWW. editor. Progress in Obstetrics and Gynaecology. London : Churchill Livingstone, 1991 31: 31-53.
6. Huchet J, Dallemagne S, Huchet Cl, Brossard Y, Larsen M, ParnetMathieu F. Application ante-partum du traitement preventif d’immunisation Rhesus D chez les femmes Rhesus negatif. J Gynecol Obstet Biol Reprod 1987; 16: 101-111.
7. Murphy KW, Whitfield CR. Rhesus disease in this decade. Corrtetnp Rev Obstet Ggynaecol 1994; 6 61-67.
8. Huggon AM, Watson DP. Use of anti-D in an accident and emergency department. Arch Emer g Med 1993; 10: 306-309.
9. Witter FR, Shirey RS, Nicol SL, Ness PM. Postinjection kinetics of anteparturn Rh immune globulin. Am J Ohstet Gvnecol 1990; 163: 784-786.
10. Bowman JM, Pollock JM. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures. Trmsf Med 1987; 1: 101-112.
11. Lee D, Rawlinson VI. Multicentre trial of anteparturn low-dose anti-D immunoglobulin. TransfMed 1995; 5: 15-19.
12. Embrey MP, Graham NB, McNeill ME, Hillier K. In vitro release characteristics and long term stability of poly (ethylene oxide) hydrogel vaginal pessaries containing prostaglandin E:. J Control Rel 1986; 3: 39-45.
13. Bowman JM, Pollock JM, Penston LE. Fetomaternal transplacental haemorrhage during pregnancy and after delivery. Vox Sang 1986; 51: 117-121.
14. Baroness Cumberlege. Changing Childbirrh Purr I: Reporr ofrhe Expert Muferniv Group London : HMSO., 1993.
15. Hussey RM, Clarke CA. Deaths from Rh haemolytic disease in England and Wales in 1988 and 1989. BMJ 1991; 303: 445-446.
16. Whitfield CR, Raafat A, Urbaniak SJ. Underreporting of mortality from RhD haemolytic disease in Scotland and its implications: retrospective review. BMJ 1997; 315: 1504-1505.
17. MacKenzie IZ, Bowell PJ, Selinger M. Deaths from haemolytic disease of the newborn. BMJ 1992; 304: 1175-1176.
18. Bowell P, Wainscoat JS, Peto TE, Gunson HH. Maternal anti-D conccntrations and outcome in rhesus haemolytic disease of the newborn. BMJ 1982; 285: 327-329.
19. Bowman JM. Haemolytic disease of the newborn. Baill Clin Immunol Allerg 1987; 1: 391-425.
20. Stevenson RC, Pharoah POD, Stevenson CJ, McCabe CJ, Cooke RWI. Cost of care for a geographically determined population of low birthweight infants to age 8-9 years. 11. Children with disability. Arch Dis Child 1996; 74: F118-F121.
21. Johnson A, Townshend P, Yudkin P, Bull D, Wilkinson AR. Functional abilities at age 4 years of children born before 29 weeks of gestation. BMJ 1993; 306: 1715-1718.
22. Vick S, Cairns J, Urbaniak S, Whitfield C, Raafat A. Cost-effectiveness of antenatal anti-D prophylaxis. Healrh Econ 1996; 5: 319-328.
23. Urbaniak SJ. Royal College of Physicians of EdinburghRoyal College of Obstetricians and Gynaecologists Consensus Conference on anti-D prophylaxis; 1997 Apr 7-8. Transf Med 1997; 7: 143-144.
24. De Silva M, Teesdale P, Contreras M. Supplies of anti-Rh (D). BMJ 1988; 296: 132.